glp-1 agonists uses Agonists: A Comprehensive Overview GLP-1 Drug Savings: A Complete
Description
After stopping, the weight returns

doi: 10.1093/eurheartj/ehac530 72 MebazaaADavisonBChioncelOCohen-SolalADiazRFilippatosGet al

[DOI] [PMC free article] [PubMed] [Google Scholar] 64.Zakariassen HL, John LM, Lutz TA

Pierre-Louis: So, for example, I had an ankle injury a couple years back

The reviewed data show that maternal exposure to GLP-1 agonists causes reduced embryonic-fetal survival, increases in major congenital anomalies, reduced fetal weight/growth, retardation of ossification, irregular ossification and skeletal variants in mice, rats and rabbits

Any dietary changes should be implemented as part of a comprehensive management plan that includes regular monitoring of glycaemic control, weight, and treatment response
